The Business Case for Diversity: Dynamic Strategies for Promoting Diversity and Inclusion

4:00 PM - 5:15 PM, Monday, June 3,2019 ・ 118B, Level 100
In 2015, McKinsey and Co.published their groundbreaking Diversity Matters report with data demonstrating a more diverse leadership team meant a better bottom line. The companies in the top quartile of gender diversity were 15 percent more likely to have financial returns above their national industry median. Several organizations are leading initiatives to raise the profile of women and underrepresented groups within the biopharmaceutical industry implementing strategies to promote upward mobility. Large and small companies alike are rising to the challenge to reframe how the industry thinks and speaks about diversity. This session will focus on practical approaches and successful examples to creating inclusive cultures for development/retention and better aligning organizations with the full measure of talented people available.
Moderator
photo
President & Chief Executive Officer
Halozyme Therapeutics
Speakers
photo
President & Chief Executive Officer
Halozyme Therapeutics
photo
CEO
Frequency Therapeutics
photo
Chief Executive Officer and Director of the Board
Immunocore
photo
Global Head, Corporate Responsibility & Inclusion
Thomson Reuters